1) maitansine
美坦辛
2) Tamsulosin
坦索罗辛
1.
Tamsulosin enhances lower ureteral stone clearance with extracorporeal shockwave lithotripsy;
坦索罗辛在输尿管下段结石体外震波碎石术后辅助排石中的作用
2.
Tamsulosin enhances lower ureteral stone clearance with extracorporeal shock wave lithotripsy;
坦索罗辛在输尿管下段结石ESWL后辅助排石中的作用
3.
Tamsulosin in chronic pelvic pain syndrome:A prospective study;
坦索罗辛治疗慢性盆底痛综合征的研究
3) Finasteride
坦素罗辛
1.
Evaluation of the Effectiveness of Terazosin, Tamsulosin a nd Finasteride for Benign Prostatic Hyperplasia;
特拉唑嗪、非那司提和坦素罗辛治疗良性前列腺增生症的有效性评价
4) Tamsulosin
坦索洛辛
1.
Levofloxacin alone was used in group A, Levofloxacin and Tamsulosin were used in group B, and Levofloxacin, Tamsulosin and Fenbid were used in group C.
方法门诊收治的186例难治性Ⅲ型前列腺炎患者,随机分为A、B、C3组,A组单用左氧氟沙星治疗,B组选用左氧氟沙星+坦索洛辛治疗,C组选用左氧氟沙星+坦索洛辛+芬必得治疗,疗程4~8周。
5) Olmesartan
奥美沙坦
1.
Determination of olmesartan concentration by LC-MS-MS assay in the human plasma;
LC-MS-MS方法检测人血浆中奥美沙坦的浓度
2.
Pharmacokinetics and bioequivalence of olmesartan medoxomil capsules;
奥美沙坦酯胶囊的人体药动学及生物等效性
3.
Efficacy and safety of olmesartan medoxomil tablet in patients with mild to moderate primary hypertension;
奥美沙坦治疗轻、中度原发性高血压的疗效和安全性
6) exemestane
依西美坦
1.
Effect of Exemestane in Treatment of Postmenopausai Women with Advanced Breast Cancer;
依西美坦治疗绝经后晚期乳腺癌的疗效观察
2.
Inhibition effect of exemestane in endometrial carcinoma cell line HHUA in vitro;
依西美坦对子宫内膜癌细胞HHUA体外增殖的抑制作用
3.
Determination of Exemestane Tablets by RP-HPLC;
RP-HPLC法测定依西美坦片的含量
补充资料:坦索罗辛
分子式:暂无
分子量:暂无
CAS号:106133-20-4
性质:暂无
制备方法:暂无
用途:泌尿系统用药。
分子量:暂无
CAS号:106133-20-4
性质:暂无
制备方法:暂无
用途:泌尿系统用药。
说明:补充资料仅用于学习参考,请勿用于其它任何用途。
参考词条